Microsure BV is pleased to announce the appointment of Mr. Michel Therin as the new Chair of its Supervisory Board, succeeding Mr. Harry Borggreve, who has served with distinction as a member and Chair over the past five years.
As Microsure moves into a new and exciting chapter—heading toward the launch of the MUSA 3 surgical robot—Mr. Therin’s deep expertise in medtech, particularly in the fields of surgical robotics and advanced medical devices, positions him to provide critical leadership in this transformative phase. His strategic vision and broad industry experience will be invaluable as Microsure accelerates the global roll-out of its breakthrough microsurgical robot.
Guiding Microsure into the Future of Precision Surgery
Mr. Therin’s leadership will significantly strengthen Microsure’s position in the rapidly evolving surgical robotics market. With the upcoming commercial introduction of the MUSA 3 microsurgical robot—a game-changing technology that promises to revolutionize microsurgery—Mr. Therin’s vast experience in scaling complex medical technologies and guiding high-growth companies will be instrumental in achieving key milestones, including securing upcoming regulatory clearances in Europe and the USA.
Commenting on his appointment, Iwan van Vijfeijken, CEO of Microsure, said, “We are excited to welcome Michel to the Board as our new Chair. His deep understanding of both the business and technological sides of medtech, combined with his strategic insights into commercialization, will be crucial as we expand Microsure’s reach globally. Michel’s patient-centered innovation philosophy aligns perfectly with our mission to bring life-changing microsurgical solutions to patients worldwide.”
Mr. Therin added, “I’m thrilled to join the team at Microsure. The MUSA 3 system represents the future of microsurgery. With its enhanced precision, reduced tremor, and ability to support previously impossible surgical procedures, it is set to transform not only the way surgery is performed but also the lives of patients who will benefit from these advancements. I look forward to helping guide the company through this critical growth phase.”
A Proven Leader in Medtech Innovation
Michel Therin brings over 30 years of leadership experience in the medtech sector, particularly within surgical robotics and advanced medical devices. Mr. Therin has a strong track record of providing strategic guidance as Chairman and/or Board member
of various medical technology companies, including Ganymed Robotics, Caranx Medical, and Artedrone.
His extensive background includes serving as President of Siemens Healthineers’ Advanced Therapies Division, where he led key interventional imaging strategies and was instrumental in high-profile acquisitions totaling nearly €18 billion. He has held senior roles at Medtronic, including Global Vice President and General Manager of multiple divisions, and has led breakthrough innovations in the R&D and commercialization of medical devices.
Acknowledging Outgoing Chair, Harry Borggreve
The company extends its heartfelt gratitude to Mr. Harry Borggreve for his exemplary service as both Board member and Chair. His leadership has been instrumental in shaping Microsure’s development and strategic direction for the last five years.
About Microsure BV
Microsure is a leading medical technology company based in Eindhoven, The Netherlands, dedicated to advancing microsurgical robotics. Its third-generation surgical robot, MUSA 3, integrates advanced features such as enhanced dexterity, tremor filtration, and ergonomic surgeon consoles, designed to elevate precision in delicate microsurgical procedures and improve patient outcomes.
For more information, media inquiries, or to schedule interviews, please contact:
Microsure BV, Science Park Eindhoven 5080, 5692 EA Son, The Netherlands. Tel: +31 40 231 1005 | Email: info@microsure.nl
